Search details
1.
Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial.
Crit Care
; 28(1): 65, 2024 02 29.
Article
in English
| MEDLINE | ID: mdl-38424569
2.
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Crit Care
; 27(1): 226, 2023 06 08.
Article
in English
| MEDLINE | ID: mdl-37291677
3.
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.
Eur Respir J
; 60(6)2022 12.
Article
in English
| MEDLINE | ID: mdl-35896211
4.
Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
J Cardiovasc Pharmacol
; 80(6): 783-791, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-35976136
5.
Increased day-to-day fluctuations in exhaled breath profiles after a rhinovirus challenge in asthma.
Allergy
; 76(8): 2488-2499, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33704785
6.
Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients.
Nat Commun
; 15(1): 744, 2024 Jan 25.
Article
in English
| MEDLINE | ID: mdl-38272877
7.
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19.
Eur J Pharm Sci
; 184: 106418, 2023 May 01.
Article
in English
| MEDLINE | ID: mdl-36870577
8.
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
CPT Pharmacometrics Syst Pharmacol
; 10(12): 1497-1511, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34608769
9.
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Lancet Respir Med
; 9(9): 957-968, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34147142
10.
Long-term clinical outcomes of COVID-19 patients treated with imatinib.
Lancet Respir Med
; 10(4): e34-e35, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35183270
Results
1 -
10
de 10
1
Next >
>>